In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity

Manuel Kley1, Seraina O Moser1, Denise V Winter2

  • 1Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Swiss Centre for Applied Human Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Methods in Enzymology
|October 6, 2023
PubMed
Summary

11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2) protects against excess mineralocorticoid and glucocorticoid receptor activation. This summary details in vitro methods to assess 11β-HSD2 activity and identify potential inhibitors.

Related Concept Videos